Creation of a versatile therapeutic platform using autologous gene-engineered B cell protein factories to make durable therapies for patients with genetic diseases
Year: 2024
Type: article
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4391379977
